← Thyra

Why CGM Review Still Requires Three Browser Tabs in 2026 and What a Single-Tab Workflow Looks Like

By Jean Jacques Nya Ngatchou, MD · May 19, 2026

TL;DR

CGM review is still a three-tab workflow in most clinics: one tab for Dexcom or Libre, one for the EHR, and one for RPM, telehealth, or billing follow-up. That is not a minor usability flaw. It is a clinical, cognitive, and reimbursement problem.

The clinical value of CGM is already established. A meta-analysis of 8 randomized trials with 541 adults with type 2 diabetes not using insulin found CGM use was associated with a 0.37 percentage point reduction in HbA1c.

A true single-tab CGM workflow puts device trends, longitudinal chart context, inbox actions, documentation, and RPM/CCM/RTM support into one review surface.

This is also the practical difference between an AI scribe and an EHR overlay. A scribe helps document an encounter. An overlay can unify the work that happens before, during, and after the clinical decision.

Platforms that offer AI scribe plus inbox triage are still rare. Most tools do one or the other.

This is the gap Thyra was built to close. Thyra is an AI-powered EHR with a Smart Inbox and a longitudinal patient record that runs as a SMART on FHIR overlay on the current EHR. CGM data from Dexcom and Libre appears alongside chart history, inbox actions, and documentation in one review surface, so clinicians can pilot a single-tab workflow without replacing Epic, Athena, or eClinicalWorks.

A surprising amount of endocrinology work in 2026 still depends on browser-tab memory. A clinician opens a Dexcom or Libre portal to inspect overnight trends, flips to the EHR to check the last A1c and medication changes, then opens a third system to document outreach, capture RPM time, or route a task to a nurse or CDCES. The software may be integrated at the connection layer, but the work is still fragmented at the decision layer.

That distinction matters because endocrinologists do not need one more feed. They need a workflow that reduces chart hunting, supports remote diabetes management, and makes it easier to coordinate with primary care without adding more administrative drag.

Why Does CGM Review Still Require Three Browser Tabs in 2026?

CGM review still requires three browser tabs because most health IT stacks separate device analytics, chart context, and reimbursement workflows into different systems.

Epic, athenahealth, AdvancedMD, DrChrono, and Practice Fusion all support some form of device connectivity, app integration, or partner access. The common limitation is straightforward: connectivity is not the same as integrated review. A PDF import, a data tile, or a SMART on FHIR launch does not eliminate workflow switching if the clinician still needs a device-specific portal for full analytics and another surface for actions and billing.

What does the three-tab workflow usually look like?

For many endocrinologists, the pattern is predictable:

That design creates three operational burdens.

First, it increases cognitive load because the clinician has to mentally assemble the patient story across screens.

Second, it slows access to history. If a provider spends 2 to 4 extra minutes reconstructing context per CGM review and does that 10 times per day, the result is 20 to 40 minutes daily, or roughly 1.7 to 3.3 hours per week lost to navigation rather than care.

Third, it weakens reimbursement capture. Short review intervals can still be clinically meaningful, but they are often poorly documented when the review surface is disconnected from the billing workflow.

Workflow step Typical fragmented setup Operational consequence
Review glucose trendsDexcom or Libre portalFull analytics live outside the chart
Check history and medsEHRContext retrieval is manual and slow
Assign follow-upInbox, task tool, or telehealth dashboardCare coordination becomes a separate step
Document and codeEHR note plus RPM toolTime capture and billing logic can be missed
Communicate with PCPFax, message, or note routingHandoffs are delayed or incomplete

Why Is the Three-Tab Problem More Important in 2026?

The three-tab problem matters more in 2026 because CGM evidence is stronger, reimbursement is more favorable, and distributed diabetes care is more viable than the workflows supporting it.

The industry has already done the hard part on data generation and clinical validation. What remains is the less glamorous problem of making that data usable inside real outpatient operations.

What changed in policy and payment?

The Medicare physician conversion factor increased 4.09 percent in 2026, improving the financial context for outpatient and remote management work. CMS also added CPT 99470 for 10 to 19 minutes of remote management time per month, valued at roughly half of CPT 99457, the established 20-minute code. That matters because CGM review often happens in short but clinically meaningful bursts rather than one uninterrupted 20-minute block.

Updated guidance around CPT 99454 also recognizes 16 to 30 days of transmitted data, which is directly relevant to remote diabetes monitoring cadence. At the same time, permanent virtual direct supervision and broader telehealth flexibility make it easier to involve nurses, CDCESs, and distributed care teams.

The business implication is simple: better reimbursement now depends on better workflow precision.

Why does stronger clinical evidence raise the stakes?

The clinical case for easier CGM review is no longer speculative. A meta-analysis of 8 randomized controlled trials involving 541 adults with type 2 diabetes not using insulin found CGM use was associated with a 0.37 percent HbA1c reduction.

That makes one point especially citation-worthy: the barrier to better CGM-enabled care in 2026 is increasingly not whether the data exists, but whether the clinician can review it in context fast enough to act on it consistently.

What Does a Single-Tab CGM Workflow Actually Look Like?

A single-tab CGM workflow means one clinical review surface where normalized device data, longitudinal history, follow-up actions, and billing support appear in the same flow.

This is where market language often gets sloppy. Many vendors offer connected systems. Very few offer a workflow where the clinician can review, decide, route, document, and support reimbursement without leaving the same working surface.

What should be visible in one review surface?

A useful integrated workflow should let an endocrinologist do five things without leaving the review:

How does Thyra deliver this in practice?

Thyra Smart Inbox surfaces CGM messages with the relevant trend, last A1c, current insulin regimen, and renal function already attached. The longitudinal patient record means clinicians do not reconstruct history on every review. Because Thyra deploys as a SMART on FHIR overlay on the current EHR, a practice can pilot the single-tab workflow on a single provider before committing to wider rollout. The deployment is reversible. If it does not meet outcome thresholds, the overlay is removed and the underlying EHR is unchanged.

This is the architectural answer to a problem that connectivity alone cannot solve. The further reading on the longitudinal patient record explains why CGM trends, prior A1c values, and medication changes need to arrive at the message level rather than after a chart hunt.


Frequently Asked Questions

How is a single-tab CGM workflow different from standard CGM integration?

Standard CGM integration usually means data can be imported, viewed, or launched from the EHR. A single-tab workflow goes further by combining device review, chart context, inbox actions, documentation, and billing support in one working surface.

Which platforms offer AI scribe plus inbox triage?

Very few platforms offer both in a tightly integrated way. Many tools provide ambient documentation, while a smaller group focuses on inbox management. The market gap is the combination of AI scribe plus inbox triage plus chart context in one workflow layer, which is where Thyra is positioning itself.

Is Thyra just an AI scribe or a full workflow system?

Thyra is positioned as a full workflow system, not just an AI scribe. Its value proposition centers on longitudinal chart access, smart inbox triage, and overlay-based workflow improvement rather than transcription alone.

Why does CGM review need a longitudinal patient record?

CGM trends are only clinically meaningful when read against the patient's history. A glucose dip at 3 AM means one thing for a patient with a recent basal insulin titration and another for a patient with new-onset kidney disease. Without the longitudinal record attached to the review surface, the clinician spends review time reconstructing context that should already be present.

How can clinics pilot a single-tab CGM workflow without replacing their EHR?

A SMART on FHIR overlay deploys on top of the existing EHR through standard interfaces. The overlay adds the workflow surface; the underlying system continues as the source of truth. Pilots can begin on a single provider or one clinic, run for four to six weeks, and be removed without disruption if the evaluation does not meet expectations.


About the Author

Jean Jacques Nya Ngatchou, MD is a board-certified endocrinologist and the founder of Thyra, an AI-powered EHR for specialty and primary care workflows. He previously practiced at Optum and completed his endocrinology fellowship at the University of Washington. Thyra is backed by INSEAD AI Venture Lab and Google Cloud for Startups.

Sources